Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China · Delayed Price · Currency is CNY 13.88
+0.27 (1.98%)
Jul 30, 2026, 9:25 AM CST
SHE:002020 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 4,036 | 4,069 | 4,159 | 3,999 | 3,780 | 3,467 |
Revenue Growth | -0.43% | -2.15% | 3.99% | 5.79% | 9.04% | 6.40% |
Gross Profit Gross Profit Growth | 2,022 | 2,007 | 2,061 | 2,011 | 2,006 | 1,920 |
Operating Income Operating Income Growth | 789.1 | 769.85 | 714.56 | 579.08 | 613.8 | 577.8 |
Net Income Net Income Growth | 759.89 | 757.98 | 711.96 | 618.9 | 662.25 | 612.54 |
Earnings Per Share EPS Growth | 0.92 | 0.92 | 0.83 | 0.72 | 0.77 | 0.75 |
EPS Growth | 10.76% | 10.84% | 15.28% | -6.49% | 2.67% | -8.54% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Inter-segment elimination Inter-segment elimination Growth | -1,478 |
Finished drug Business Finished drug Business Growth | 2,593 |
Medical device Business Medical device Business Growth | 696.25 |
Other Business Other Business Growth | 392.76 |
Active Pharmaceutical Ingredient Sales Active Pharmaceutical Ingredient Sales Growth | 1,865 |
Total Total Growth | 4,069 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 849.67 | 849.67 | 1,144 | 1,612 | 1,915 | 1,983 |
Total Debt Total Debt Growth | 313.65 | 313.65 | 317.79 | 322.18 | 296.3 | 193.92 |
Net Cash (Debt) Net Cash Growth | 536.02 | 536.02 | 826.13 | 1,290 | 1,619 | 1,789 |
Net Cash Growth | 13.29% | -35.12% | -35.94% | -20.35% | -9.51% | -4.00% |
Net Cash Per Share Net Cash Per Share Growth | 0.65 | 0.65 | 0.96 | 1.50 | 1.88 | 2.19 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 800.31 | 781.35 | 726.16 | 792.84 | 855.78 | 373.46 |
Capital Expenditures CapEx Growth | -187.94 | -202.85 | -250.65 | -519.51 | -515.57 | -406.83 |
Free Cash Flow Free Cash Flow Growth | 612.37 | 578.5 | 475.52 | 273.32 | 340.2 | -33.37 |
Free Cash Flow Growth | 136.23% | 21.66% | 73.98% | -19.66% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 50.09% | 49.31% | 49.56% | 50.30% | 53.06% | 55.39% |
Operating Margin | 19.55% | 18.92% | 17.18% | 14.48% | 16.24% | 16.67% |
Pretax Margin | 21.37% | 21.24% | 20.30% | 17.71% | 19.85% | 20.18% |
Profit Margin | 18.83% | 18.63% | 17.12% | 15.48% | 17.52% | 17.67% |
FCF Margin | 15.17% | 14.22% | 11.43% | 6.83% | 9.00% | -0.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.350 | 0.350 | 0.350 | 0.300 | 0.300 | 0.300 |
Dividend Per Share Growth | 0% | 0% | 16.67% | 0% | 0% | 2.84% |
Dividend Yield | 2.57% | 1.90% | 2.89% | 2.56% | 2.72% | 3.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 15.09 | 20.38 | 15.48 | 17.70 | 15.84 | 13.37 |
Forward PE | - | 17.99 | 14.75 | 14.91 | 13.98 | 10.14 |
P/FCF Ratio | 18.44 | 26.70 | 23.18 | 40.07 | 30.83 | - |
PS Ratio | 2.80 | 3.80 | 2.65 | 2.74 | 2.78 | 2.36 |